Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer. | Cancer Immunol Immunother | 2024 | 38294569 | PubTator, text mining | PubMed |
| Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma. | Sci Rep | 2024 | 38287061 | PubTator, text mining | PubMed |
| Semi-supervised integration of single-cell transcriptomics data. | Nat Commun | 2024 | 38287014 | PubTator, text mining | PubMed |
| Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions. | Genome Med | 2024 | 38281962 | PubTator, text mining | PubMed |
| Macrophage barrier in the tumor microenvironment and potential clinical applications. | Cell Commun Signal | 2024 | 38279145 | PubTator, text mining | PubMed |
| Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma. | BMC Pulm Med | 2024 | 38273291 | PubTator, text mining | PubMed |
| LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy. | J Immunother Cancer | 2024 | 38272565 | PubTator, text mining | PubMed |
| Anti-correlated feature selection prevents false discovery of subpopulations in scRNAseq. | Nat Commun | 2024 | 38267438 | PubTator, text mining | PubMed |
| Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma. | Nat Commun | 2024 | 38245530 | PubTator, text mining | PubMed |
| The effector program of human CD8 T cells supports tissue remodeling. | J Exp Med | 2024 | 38226976 | PubTator, text mining | PubMed |
| Immune checkpoint expression patterns on T cell subsets in light-chain amyloidosis: VISTA, PD-1, and TIGIT as potential therapeutic targets. | Blood Sci | 2024 | 38226018 | PubTator, text mining | PubMed |
| Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy. | Korean J Intern Med | 2024 | 38225824 | PubTator, text mining | PubMed |
| Construction of an abnormal glycosylation risk model and its application in predicting the prognosis of patients with head and neck cancer. | Sci Rep | 2024 | 38225277 | PubTator, text mining | PubMed |
| Expression of PD-1 mitigates phagocytic activities TAM in osteosarcoma. | Heliyon | 2024 | 38223729 | PubTator, text mining | PubMed |
| CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer. | Immunotargets Ther | 2024 | 38223406 | PubTator, text mining | PubMed |
| The presence of Y chromosome leads to the difference of cancer in patients with different sexes. | MedComm (2020) | 2024 | 38222317 | PubTator, text mining | PubMed |
| Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications. | Virol J | 2024 | 38216935 | PubTator, text mining | PubMed |
| Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. | Nat Immunol | 2024 | 38212464 | PubTator, text mining | PubMed |
| Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites. | J Immunother Cancer | 2024 | 38212122 | PubTator, text mining | PubMed |
| Fractal feature selection model for enhancing high-dimensional biological problems. | BMC Bioinformatics | 2024 | 38195379 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=13